Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$3.77
$0.3359.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 74.19% | -52.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 66.07% | -41.76% | |||
| Operating Income | -66.07% | 41.76% | |||
| Income Before Tax | -90.99% | 57.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -90.99% | 57.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -90.99% | 57.76% | |||
| EBIT | -66.07% | 41.76% | |||
| EBITDA | -66.18% | 41.81% | |||
| EPS Basic | 6.64% | 79.50% | |||
| Normalized Basic EPS | 6.64% | 74.44% | |||
| EPS Diluted | 24.09% | 74.79% | |||
| Normalized Diluted EPS | 6.64% | 74.44% | |||
| Average Basic Shares Outstanding | 104.56% | 106.04% | |||
| Average Diluted Shares Outstanding | 104.56% | 106.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||